APP PHARAMACEUTICALS

APP Pharamaceuticals is a specialty pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products. We currently produce over 100 generic injectable pharmaceutical products in more than 300 dosages and formulations. Their primary focus is in the oncology, anti-infective and critical care markets, and they believe they offer one of the most comprehensive generic injectable product portfolios across these therapeutic categories. They have licensed ABI-007, a proprietary injectable oncology product candidate that is a patented formulation of paclitaxel.